Radium-223 (Ra-223) versus novel antihormone therapy (NAH) for progressive metastatic castration-resistant prostate cancer (mCRPC) after 1 line of NAH: RADIANT, an international phase 4, randomized, open-label study.
Fizazi K., Gonzalez del Alba A., Mustafa O., Skoneczna I. A., Krissel H., Uema D., ...Daha Fazla
JOURNAL OF CLINICAL ONCOLOGY, cilt.39, sa.15, 2021 (SCI-Expanded, Scopus)
-
Yayın Türü:
Makale / Özet
-
Cilt numarası:
39
Sayı:
15
-
Basım Tarihi:
2021
-
Doi Numarası:
10.1200/jco.2021.39.15_suppl.tps5093
-
Dergi Adı:
JOURNAL OF CLINICAL ONCOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
-
İstanbul Üniversitesi-Cerrahpaşa Adresli:
Hayır